Advertisement

Topics

Using anti-PD-1 therapy pre-surgery in melanoma patients can identify those most likely to benefit

20:00 EDT 14 Apr 2018 | AAAS

(University of Pennsylvania School of Medicine) Checkpoint inhibitors that block the protein PD-1 are used in melanoma patients after they've had surgery to remove their cancer, but not all patients benefit from the immunotherapy. Now a new study from the Abramson Cancer Center of the University of Pennsylvania found that shifting use of anti-PD-1 drugs to before surgery may provide clues about which patients will benefit and which may be at increased risk for recurrence.

Original Article: Using anti-PD-1 therapy pre-surgery in melanoma patients can identify those most likely to benefit

NEXT ARTICLE

More From BioPortfolio on "Using anti-PD-1 therapy pre-surgery in melanoma patients can identify those most likely to benefit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...